1. Brodie, B.B., and Hogben, C.A.M., 1957, Some physico-chemical factors in drug action, J. Pharm. Pharmacol. 9: 345–380.
2. Brown, J.H., Mackey, H.K., and Rigillo, D.A., 1967, A novel in vitro assay for anti-inflammatory agents based on stabilization of erythrocytes, Proc.Soc. exp. Biol. Med. 125: 837–843.
3. Bunting, S., Moncada, S., Needleman, P., and Vane, J.R., 1976a, Prostaglandin endoperoxides and thromboxane generating systems and their selective inhibition, Br. J. Pharmac. 56: 334P–345P.
4. Bunting, S., Moncada, S., and Vane, J.R., The effects of prostaglandin endoperoxides and thromboxane A2 on strips of rabbit coeliac artery and certain other smooth muscle preparations, Proc. Br. Pharmacol. Soc. 1–2 April 1976b, p.48.
5. Caprino, L., Borelli, F., and Falchetti, R., 1973b, Effect of 4,5-diphenyl-2-bis-(2-hydroxyethyl)-ami-noxazol (Ditazol) on platelet aggregation, adhesiv-ness and bleeding time, Arzneimittel Forsch. 23; 1277–1283.